header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O2632 100% 10-YEAR SURVIVAL OF A HYBRID TOTAL HIP REPLACEMENT (MS-30 CEMENTED STEM AND MORSCHER PRESS-FIT CUP)



Abstract

Aims: We report 10-year results of the THR hybrid system. Femoral Component: Morscher-Spotorno MS-30¨, stainless steel, tapered, with- out collar with matte surface, þxed with Palakos¨+ Gentamycine bone cement. Cup: non-cemented Morscher Press-Fit Cup¨. Material and methods: A consecutive series of 123 THRs in 120 patients (75 female, 45 male) operated on between January 1990 and December 1992 were subjected to follow-up at 10 years. Mean age at surgery was 69 in women, 71 in men. No patients were lost to follow-up. 23 patients (19%) died without needing a revision, and 12 (10%) could only be inter- viewed by phone. Of the remaining 85 patients (71%) with 88 hips (70%) were available for complete evaluation. Mean follow-up was 9.8 (8.0 Ð 12.2 years).Results: Harris Hip scores were excellent and good in 84% (71 pts), moderate in 14% (12 pts) and poor in 2% (2 pts with rheumatoid arthritis). No stems or cups had to be revised. Radiographically 15 hips (13%) had femoral stem-related osteolyses Ð mostly in Gruen zones 2, 6 and 7. 8 stems subsided 2 Ð 5 mm. No infection and no acetabular osteolysis was observed. Conclusion: In 1990, the MS-30 stem was only available with a matte surface, which can impede settling and consequent maintenance of proximal load transfer to bone. Thus, although no revisions were necessary, the 13% osteolyses may relate to the matte surface. From 1994 on, the MS-30 stem has been available with a polished surface. The excellent outcome for the Morscher Press-Fit Cup corresponds to results in other series.

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.